Skip to content

Study · Not a test of the peptide alone · 2005

2 results

Construction and expression of a new fusion protein, thymosin alpha1-cBLyS, E. coli.

Shen Q, Tian R, Ma W, Yuan Q, Gong Y

Biotechnology letters1 Feb 2005Cited by 6 (Europe PMC)

PMID15717121 (opens in a new tab)DOI10.1007/s10529-004-7333-3 (opens in a new tab)PepBankPUB-15717121
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01LabNot a test of Thymosin alpha-1 aloneOther designOther

    The expressed thymosin alpha‑1-cBLyS fusion protein had a molecular weight of approximately 28 kDa.

    In plain wordsIn lab tests, the fusion protein made from thymosin alpha‑1 and a second protein was about 28 kDa in size.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableFusion protein molecular weight
    Study

    n: not reported in source

    Outcome group
    Analytical methods and detection · Pharmacology

    Measurements

    Molecular weight
    ≈ 28 kDa
    TM alpha1-cBLyS fusion protein

    Source sentences

    Summary
    The molecular weight of the expressed fusion protein was approximately 28 kDa.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

  2. 02LabNot a test of Thymosin alpha-1 aloneOther designActivity measurement

    The thymosin alpha‑1-cBLyS fusion protein had full BLyS activity and a slightly higher immunological action than synthetic thymosin alpha‑1.

    In plain wordsIn lab tests, a fusion protein of thymosin alpha‑1 and BLyS had slightly higher immune activity than synthetic thymosin alpha‑1.

    Peptide
    Thymosin alpha-1
    Outcome
    IncreaseImmunological activity of fusion protein
    Study

    n: not reported in source

    Comparator
    Synthetic TMalpha1
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    After being purified by Ni-NTA affinity column, the fusion protein had full activity of BLyS with a slightly higher immunological action than synthetic TMalpha1.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.